Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
NOVT
Upturn stock ratingUpturn stock rating

Novanta Inc (NOVT)

Upturn stock ratingUpturn stock rating
$118.17
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: NOVT (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

4 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $141.5

1 Year Target Price $141.5

Analysts Price Target For last 52 week
$141.5 Target price
52w Low $98.76
Current$118.17
52w High $186.75

Analysis of Past Performance

Type Stock
Historic Profit -26.13%
Avg. Invested days 52
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 4.25B USD
Price to earnings Ratio 69.92
1Y Target Price 141.5
Price to earnings Ratio 69.92
1Y Target Price 141.5
Volume (30-day avg) 4
Beta 1.48
52 Weeks Range 98.76 - 186.75
Updated Date 08/15/2025
52 Weeks Range 98.76 - 186.75
Updated Date 08/15/2025
Dividends yield (FY) -
Basic EPS (TTM) 1.69

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-08-05
When -
Estimate 0.73
Actual 0.76

Profitability

Profit Margin 6.41%
Operating Margin (TTM) 11.4%

Management Effectiveness

Return on Assets (TTM) 5.49%
Return on Equity (TTM) 8.16%

Valuation

Trailing PE 69.92
Forward PE -
Enterprise Value 4654498975
Price to Sales(TTM) 4.44
Enterprise Value 4654498975
Price to Sales(TTM) 4.44
Enterprise Value to Revenue 4.86
Enterprise Value to EBITDA 25.4
Shares Outstanding 35973600
Shares Floating 35635479
Shares Outstanding 35973600
Shares Floating 35635479
Percent Insiders 0.86
Percent Institutions 104.34

ai summary icon Upturn AI SWOT

Novanta Inc

stock logo

Company Overview

overview logo History and Background

Novanta Inc. was founded in 1996 and evolved from General Scanning. It focuses on designing and manufacturing high-tech components and subsystems for medical and industrial applications. Key milestones include acquisitions and product innovations enhancing its market position.

business area logo Core Business Areas

  • Precision Medicine and Manufacturing: Provides photonics, vision, and precision motion solutions for medical device manufacturing and advanced industrial applications. Key products include laser beam delivery components, optical coherence tomography (OCT) systems, and precision motion controllers.
  • Vision: Develops and delivers advanced machine vision systems that enable manufacturers to automate and improve productivity across a range of industrial applications. They make cameras and systems for quality assurance, defect detection and metrology.
  • Robotics and Automation: Offers precision motion control solutions, including motors, drives, and encoders, that are used in robotics, automation, and other high-performance applications.

leadership logo Leadership and Structure

The leadership team includes Matthijs Glastra (CEO) and Robert Buckley (CFO). The organizational structure is based on business segments (Precision Medicine and Manufacturing, Vision, and Robotics and Automation) with centralized functions for finance, HR, and operations.

Top Products and Market Share

overview logo Key Offerings

  • Laser Beam Steering Components: Provides components used in laser-based medical and industrial applications for precise beam manipulation and control. Competitors include Coherent, IPG Photonics, and Jenoptik. No specific market share data available, but Novanta is a key player in this segment. Revenue from the product contributes significantly to the Precision Medicine and Manufacturing segment.
  • Optical Coherence Tomography (OCT) Systems: Develops and markets OCT systems used for medical imaging, particularly in ophthalmology and cardiology. Competitors include Carl Zeiss Meditec, Topcon, and Heidelberg Engineering. No specific market share available, revenue is included in the Precision Medicine and Manufacturing segment.
  • Vision Systems: Supplies embedded vision systems for industrial applications. Competitors are Cognex, Keyence, and Teledyne. Market share data not readily available. Revenue is included in Vision segment and varies by application.

Market Dynamics

industry overview logo Industry Overview

The market is driven by increasing demand for automation, precision medicine, and advanced manufacturing. Technological advancements and increasing healthcare spending are key growth drivers.

Positioning

Novanta Inc. is positioned as a leading supplier of high-tech components and subsystems for medical and industrial applications, with a focus on innovation and customized solutions. Competitive advantages include deep technical expertise and a broad product portfolio.

Total Addressable Market (TAM)

Estimated TAM for laser and motion control solutions within medical and industrial applications is in the billions of dollars globally. Novanta is positioned to capture a significant portion of this TAM through product development and strategic acquisitions.

Upturn SWOT Analysis

Strengths

  • Strong market position in niche markets
  • Diversified product portfolio
  • Focus on innovation and technology
  • Experienced management team
  • Strategic acquisitions

Weaknesses

  • Reliance on specific end markets
  • Exposure to economic cycles
  • Integration risks associated with acquisitions
  • High valuation multiples compared to peers

Opportunities

  • Expanding into new geographic markets
  • Developing new products and applications
  • Acquiring complementary businesses
  • Leveraging partnerships and collaborations

Threats

  • Increased competition
  • Technological obsolescence
  • Economic downturn
  • Supply chain disruptions
  • Regulatory changes

Competitors and Market Share

competitor logo Key Competitors

  • COHR
  • IPGP
  • TKTDY

Competitive Landscape

Novanta competes on technology, innovation, and customer service. Its strengths include a diversified product portfolio and a strong market position in niche markets. Competitors have larger scale and broader product offerings in some segments.

Major Acquisitions

Laser Optek

  • Year: 2020
  • Acquisition Price (USD millions): 150
  • Strategic Rationale: Expanded Novanta's capabilities in laser beam steering and delivery components.

ThingMagic

  • Year: 2010
  • Acquisition Price (USD millions): 30
  • Strategic Rationale: Added radio frequency identification (RFID) readers and modules to the product portfolio, diversifying into data collection and industrial automation.

Growth Trajectory and Initiatives

Historical Growth: Novanta has grown through organic innovation and strategic acquisitions, increasing revenue and profitability over the past decade.

Future Projections: Analyst estimates project continued revenue growth driven by demand in medical and industrial markets. Growth rates are expected to be in the mid-to-high single digits.

Recent Initiatives: Recent initiatives include launching new products, expanding into new markets, and integrating acquired businesses.

Summary

Novanta is a solid company with strong positions in specialized medical and industrial sectors. Strategic acquisitions and innovation have fueled growth, while reliance on specific markets poses a risk. Opportunities include expansion into emerging markets and developing new technologies. The overall outlook for Novanta is stable to positive given current market trends.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company reports
  • Industry analysis reports
  • Financial news outlets

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Market data and analyst estimates are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Novanta Inc

Exchange NASDAQ
Headquaters Bedford, MA, United States
IPO Launch date 2016-01-04
CEO & Chairman of the Board Mr. Matthijs Glastra
Sector Technology
Industry Scientific & Technical Instruments
Full time employees 3000
Full time employees 3000

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.